🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

13 results for “Atara” Clear

  1. ATA188

    Atara Biotherapeutics

    Primary Progressive Multiple Sclerosis

    phase 2 mab terminated

    1 trial

  2. CMV-pp65 CTLs

    Atara Biotherapeutics

    Cytomegalovirus

    phase 2 mab completed

    1 trial

  3. EBV-specific T cells (EBV-CTLs)

    Atara Biotherapeutics

    EBV-induced Lymphomas

    phase 2 mab completed

    1 trial

  4. Epstein-Barr virus-specific cytotoxic T lymphocytes (EBV-CTLs)

    Atara Biotherapeutics

    EBV-induced Lymphomas

    phase 2 mab completed

    1 trial

  5. Tabelecleucel

    Atara Biotherapeutics

    Nasopharyngeal Carcinoma

    phase 2 mab terminated

    1 trial

  6. ATA3219

    Atara Biotherapeutics

    Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

    phase 1 small molecule terminated

    1 trial

  7. ATA3219

    Atara Biotherapeutics

    Lupus Nephritis

    phase 1 small molecule terminated

    1 trial

  8. WT1-sensitized T cells

    Atara Biotherapeutics

    Leukemia

    phase 1 mab completed

    1 trial

  9. cyclophosphamide

    Atara Biotherapeutics

    Malignant Pleural Mesothelioma (MPM)

    phase 1 small molecule active

    1 trial

  10. 0.1% bromfenac ophthalmic solution

    China SXT Pharmaceuticals

    Cataract

    small molecule completed

    1 trial

  11. Dexamethasone

    First Tracks Biotherapeutics

    Cataract

    small molecule active

    1 trial

  12. Dextrometropine and 0.9% sodium chloride solution

    First Tracks Biotherapeutics

    Cataract

    small molecule active

    1 trial

  13. Subconjunctival dexamethasone and general anesthesia

    China SXT Pharmaceuticals

    Cataract

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources